Analyst firms · BofA Securities · SBRA

BofA Securities SBRA price target and rating history

Sabra Health Care REIT Inc. (SBRA) · Real Estate

BofA Securities rates Sabra Health Care REIT Inc. (SBRA) Buy with a $16 price target, as of its latest action on Oct 10, 2023. It has published 4 rating actions on SBRA since March 2022, including 3 upgrades and 1 downgrade. Across 4 firms with a SBRA price target in the last 12 months, the median target is $20.50.

Current rating
Buy
Price target
$16
Median target, all firms
$20.50
Actions on SBRA
4

BofA Securities price target on SBRA

$16$15$132023202420252026
BofA Securities price target on SBRA, each point a stated target, March 2022 to October 2023.

Every BofA Securities rating on SBRA

How other firms rate SBRA

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
HuntingtonOutperform$23Sep 10, 2026
Raymond JamesMkt PerformAug 6, 2026
Truist SecuritiesHoldJul 8, 2026
BarclaysOverweight$21Jul 7, 2026
CitigroupNeutral$19Jun 23, 2026
UBSNeutral$20Nov 18, 2025

Questions about BofA Securities and SBRA

What is BofA Securities's price target for SBRA?
BofA Securities's latest stated price target for Sabra Health Care REIT Inc. (SBRA) is $16, from its action on Oct 10, 2023.
What is BofA Securities's rating on SBRA?
BofA Securities rates SBRA Buy, a bullish rating, as of Oct 10, 2023.
When did BofA Securities last change its view on SBRA?
On Oct 10, 2023, BofA Securities upgrades to Buy from Neutral, price target $14 to $16.
How does BofA Securities's SBRA target compare with other analysts?
Across 4 firms with a SBRA price target in the last 12 months, the median target is $20.50.

More SBRA rating histories

All BofA Securities ratingsSBRA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.